ClinicalTrials.gg
RecruitingNCT06753487Updated Dec 31, 2024

"Effects of Facilitated Positional Release Technique( FPRT) Vs. Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome

An interventional study of Myofacial Release and Facilitated positional release technique in Piriformis Syndrome, sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to female participants aged 25 Years to 50 Years. Per ClinicalTrials.gov, last updated 2024-12-31.

Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as recruiting.
  • Registered 4 months after the study started (first participant enrolled Jul 2024, registered Dec 2024).
  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
25 Years to 50 Years
Sex
Female
01

Study summary

This study is a randomised control trial and the purpose of this study is to determine the "Effects of Facilitated Postional Release Technique( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome.

Read the detailed description

The purpose of this study is to determine the "Effects of Facilitated positional release technique vs manual myofascial release technique in female patietns with piriformis syndrome.

we make 2 groups control and treatment group . we give FPRT technique to treatment group and manual release technique to control group in patients with piriformis syndrome.

first we take base line readings of HIP ROMS( abduction, adduction, internal rotation, external rotation),NPRS and LEFS(lower extremity functional scale)..

after 2 weeks of treatment again we take same readings and compare both readings.

02

Conditions studied

  • Piriformis Syndrome
03

In context

Piriformis Muscle Syndrome

56 studies on the registry are indexed under Piriformis Muscle Syndrome; 23 are open to participants now.

This study's planned enrollment of 38 is close to the median of 42 across 50 interventional studies indexed under Piriformis Muscle Syndrome.

Browse Piriformis Muscle Syndrome studies →

Lead sponsor

Foundation University Islamabad is the lead sponsor of 253 studies on the registry; 140 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • patients with Piriformis syndrome
  • 25-50 years
  • Only females
  • Diagnosed piriformis syndromr
  • Pain from 2 months

Exclusion criteria

Exclusion criteria:

  • Lumbar Radiculopathy
  • Fracture
  • trauma to lumbar spine
  • surgery/ total hip relpacement
  • hip OA
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
38 participants (estimated)

Study arms

  • Experimental
    FPRT Group

    On group A we will perform FACILITATED POSITIONAL RELEASE TECHNIQUE: we perform this technique on tight PIRIFORMIS muscle.

    Procedure: Facilitated positional release technique

  • Active comparator
    Myofascial Release technique Group

    On group B we perform MANUAL MYOFASCIAL RELEASE TECHNIQUE on tight PIRIFORMIS muscle same as group A

    Procedure: Myofacial Release

Interventions

  • ProcedureMyofacial Release

    Manual Myofascial Release: Control group will receive 3- 5 repetitions of Manual Myofascial Release in Piriformis muscle i.e giving ischemic pressure on muscle directly for 90 secs and then release.

  • ProcedureFacilitated positional release technique

    FPRT: Treatment group will receive 5 repetitions of FACILITATED POSITIONAL RELEASE technique i.e applying pressure over tender area of muscle while maintaining specific postion

06

What researchers measure

Primary outcomes

  1. Change in ROM

    Using a Goniometer, specific Hip range of motions (hip abduction, adduction, internal rotation, ext.rotation) will be measured. This process involves positioning the patient in standarized position (i-e supine lying for hip adduction,abduction and sitting for external and internal rotation) aligning the fulcrum of goniometer along the hip axis of motion and recording the readings( in degrees, starts from zero and goes upto the maximum possible acheived range) when joint moves through range of motion.

    Time frame: 2 weeks

07

Study locations

1 of 1 sites recruiting
  • Foundation University College of Physical Therapy
    Rawalpindi, Punjab Province 46000, Pakistan
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Apr 2025, 8 months after the start.

Of 36 non-industry interventional studies with no phase under Piriformis Muscle Syndrome, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 12. This study's planned 8 months is above that.

Counting every sponsor, half of 36 studies reached it within 6 months; a quarter within 4 and three quarters within 12.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 3, 2024
First posted
Dec 31, 2024
StartActual
Jul 26, 2024
Primary completionEst.
Apr 1, 2025
CompletionEst.
Apr 15, 2025
Last update
Dec 31, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 31, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06753487
Responsible party
Sponsor
First posted
Dec 31, 2024
Start date
Jul 26, 2024
Primary completion
Apr 1, 2025 (estimated)
Completion
Apr 15, 2025 (estimated)
Last update
Dec 31, 2024

Study contacts

Fariya Maryam, MS-MSKPT*
Contact
fariyamaryam9@gmail.com
03102541357

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion